JUNG CASSIE (Chief Operating Officer) sold 14.3% of their position (45.79K shares) of AQUESTIVE THERAPEUTICS, INC. on the open market
Open‑market sale worth $191.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/11/2026ACC: 0001214659-26-003141
Officer· Chief Operating Officer
Since Mar 2026
+76.71K
Net shares
Net buyer
$191.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
122.50K acquired · 45.79K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+80K
Price / share
—
Trade value
—
% of position
33.2%
3/9/2026
240.77K→320.77K
Common Stock
Direct
Shares
−45.79K
Price / share
$4.17
Trade value
$191.09K
% of position
14.3%
3/10/2026
320.77K→274.98K
Total
Net shares
+34.21K
Net value
-$191.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/9/2026 | A · Award | +80K | — | — | 33.2% | 240.77K | 320.77K |
| Common Stock Direct | 3/10/2026 | S · Sale | −45.79K | $4.17 | $191.09K | 14.3% | 320.77K | 274.98K |
| Total | +34.21K | -$191.09K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
42.50K shares
Shares
+42.50K
Strike price
4.29
Held after
42.50K
Exercisable
—
3/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock42.50K shares | 3/9/2026 | A · Award | +42.50K | 4.29 | — | 42.50K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2K
Total
2K indirect2K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2K | Indirect |
| Total | 2K | 2K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported